Susquehanna International Group, LLP Syneos Health, Inc. Transaction History

Susquehanna International Group, LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$34.5 - $42.19 $760,449 - $929,951	-22,042 Reduced 36.95%	37,614 $1.59 Million
Q1 2023 May 16, 2023	BUY	$33.32 - $40.98 $1.22 Million - $1.51 Million	36,749 Added 160.43%	59,656 $2.12 Million
Q4 2022 Feb 14, 2023	BUY	$25.32 - $51.45 $580,005 - $1.18 Million	22,907 New	22,907 $840,000
Q2 2022 Aug 15, 2022	BUY	$63.06 - $84.75 $191,765 - $257,724	3,041 Added 48.96%	9,252 $663,000
Q1 2022 May 16, 2022	BUY	$74.15 - $99.36 $168,172 - $225,348	2,268 Added 57.52%	6,211 $503,000
Q4 2021 Feb 14, 2022	BUY	$86.01 - $102.89 $65,969 - $78,916	767 Added 24.15%	3,943 $405,000
Q2 2021 Aug 11, 2021	SELL	$76.44 - $89.57 $4,051 - $4,747	-53 Reduced 1.64%	3,176 $284,000
Q4 2020 Feb 16, 2021	SELL	$53.08 - $69.86 $1.61 Million - $2.12 Million	-30,345 Reduced 90.38%	3,229 $220,000
Q3 2020 Nov 16, 2020	SELL	$51.29 - $65.09 $64,727 - $82,143	-1,262 Reduced 3.62%	33,574 $1.79 Million
Q2 2020 Aug 14, 2020	BUY	$34.32 - $62.43 $52,440 - $95,393	1,528 Added 4.59%	34,836 $2.03 Million
Q1 2020 May 15, 2020	BUY	$32.64 - $73.63 $843,156 - $1.9 Million	25,832 Added 345.53%	33,308 $1.31 Million
Q4 2019 Feb 14, 2020	SELL	$48.0 - $59.55 $1.08 Million - $1.34 Million	-22,439 Reduced 75.01%	7,476 $445,000
Q3 2019 Nov 14, 2019	BUY	$46.64 - $55.39 $303,299 - $360,201	6,503 Added 27.78%	29,915 $1.59 Million
Q2 2019 Aug 16, 2019	BUY	$40.81 - $52.42 $580,481 - $745,622	14,224 Added 154.81%	23,412 $1.2 Million
Q2 2019 Aug 14, 2019	BUY	$40.81 - $52.42 $374,962 - $481,634	9,188 New	9,188 $469,000

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.